Interventions for pain with intrauterine device insertion

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 7, 2015, Pages

  Lopez, Laureen M ^a   Bernholc, Alissa ^a   Zeng, Yanwu ^a   Allen, Rebecca H ^b   Bartz, Deborah ^c   O'Brien, Paul A ^d   Hubacher, David ^a  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b WOMEN AND INFANTS HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d CENTRAL LONDON COMMUNITY HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; IBUPROFEN; KETOROLAC; LAVENDER OIL; LIDOCAINE; LIDOCAINE PLUS PRILOCAINE; MISOPROSTOL; NAPROXEN; NITRIC OXIDE DONOR; PLACEBO; PRILOCAINE; TRAMADOL; NONSTEROID ANTIINFLAMMATORY AGENT; OXYTOCIC AGENT;

ABDOMINAL PAIN; BLEEDING; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FAINTNESS; HEADACHE; HUMAN; MULTIPARA; NAUSEA; NAUSEA AND VOMITING; NULLIPARA; PAIN; PAIN INTENSITY; PAIN SEVERITY; PARACERVICAL BLOCK; PATIENT SATISFACTION; PELVIC INFLAMMATORY DISEASE; PERFORATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SHIVERING; SYSTEMATIC REVIEW; VISUAL ANALOG SCALE; VOMITING; ADVERSE EFFECTS; FEMALE; INTRAUTERINE CONTRACEPTIVE DEVICE; META ANALYSIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; IBUPROFEN; INTRAUTERINE DEVICES; LIDOCAINE; MISOPROSTOL; NAPROXEN; OXYTOCICS; PAIN; PRILOCAINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84957412031     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD007373.pub3     Document Type: Review

References (94)

1. Ahmadi Doulabi M, Tavakolian S, Mortazavi A, Akbarzade Baghban A. Effect of EMLA cream on pain of Copper IUD insertion [article in Persian]. Scientific Journal of Hamadan Nursing & Midwifery Faculty 2013;21(3):24-30.
2. Ahmadi M. A comparison of EMLA cream and placebo on pain during IUD insertion in women referred to health centers of Imam Hussein. www.irct.ir/searchresult.php?id=5698&number=4 (accessed 23 September 2014). [IRCT201209015698N4]
3. Tavakolian S, Ghorbani M, Doulabi MA, Baghban AA, Mortazavi A. Lidocaine-prilocaine cream as analgesia for IUD insertion: a prospective, randomized, controlled, triple blinded study. Global Journal of Health Science 2015;7(4):399-404.
4. Acmaz G. Lidocaine 10% spray reduces pain during intrauterine device insertion. clinicaltrials.gov/ct2/show/NCT02020551 (accessed 11 September 2014).
5. Aksoy H, Aksoy Ü, Ozyurt S, Açmaz G, Babayigit M. Lidocaine 10% spray to the cervix reduces pain during intrauterine device insertion: a double-blind randomised controlled trial. Journal of Family Planning and Reproductive Health Care 2015 Mar 10 [Epub ahead of print]:1-5.
6. Allen RH, Raker C, Goyal V. Higher dose cervical 2% lidocaine gel for IUD insertion: A randomized controlled trial. Contraception 2013; Vol. 88, issue 6:730-6.
7. Bednarek PH, Micks EA, Edelman AB, Li H, Jensen JT. The effect of nitroprusside on IUD insertion experience in nulliparous women: A pilot study. Contraception 2013;87(4):421-5.
8. Bednarek PH, Creinin MD, Reeves MF, Cwiak C, Espey E, Jensen JT. Immediate versus delayed IUD insertion after uterine aspiration. New England Journal of Medicine 2011;364(23):2208-17.
9. Bednarek PH, Creinin MD, Reeves MF, Cwiak C, Espey E, Jensen JT, Post-Aspiration IUD Randomization (PAIR) Study Trial Group. Prophylactic ibuprofen does not improve pain with IUD insertion: a randomized trial. Contraception 2015;91(3):193-7.
10. Bednarek PH, Creinin MD, Reeves MF, Cwiak C, Espey E, Mayo J, et al. Pain with IUD insertion following prophylactic ibuprofen: A randomized trial (abstract). Contraception 2010;82(2):194-5.
11. Cameron ST, Glasier A, Cooper A, Johnstone A. Does a full bladder assist insertion of intrauterine contraception?: a randomised trial. Journal of Family Planning and Reproductive Health Care 2013;39(3):207-10.
12. Castro TV, Franceschini SA, Poli-Neto O, Ferriani RA, Silva de Sa MF, Vieira CS. Effect of intracervical anesthesia on pain associated with the insertion of the levonorgestrel-releasing intrauterine system in women without previous vaginal delivery: a RCT. Human Reproduction 2014;29(11):2439-45.
13. Vitti T, Ferriani R, Vieira C. Local anaesthetic in uterine cervix is not associated with lower pain score in levonorgestrel-releasing intrauterine system insertion in women without previous vaginal delivery (abstract). European Journal of Contraception and Reproductive Health Care 2012;17(S1):S104.
14. Chor J, Bregand-White J, Golobof A, Harwood B, Cowett A. Ibuprofen prophylaxis for levonorgestrel-releasing intrauterine system insertion: A randomized controlled trial. Contraception 2012;85(6):558-62.
15. Chor J, Harwood B, Cowett A. Ibuprofen prophylaxis for levonorgestrel-releasing intrauterine system insertion: A randomized controlled trial (abstract). Contraception 2010;82(2):201-2.
16. Cirik DA, Taşkin EF, Tuğlu A, Ortaç AS, Dai O. Paracervical block with 1% lidocaine for pain control during intrauterine device insertion: a prospective, single-blinded, controlled study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 2013;2(3):263-7.
17. Dijkhuizen K, Dekkers OM, Holleboom CA, De Groot CJ, Hellebrekers BW, Van Roosmalen GJ, et al. Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Human Reproduction 2011;26(2):323-9.
18. Edelman AB, Schaefer E, Olson A, Van Houten L, Bednarek P, Leclair C, et al. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Contraception 2011;84(3):234-9.
19. Espey E, Leeman L, Greene H, Singh R, Ogburn T, Fowler K. Misoprostol for IUD insertion in nulliparous women: A randomized controlled trial (abstract). Contraception 2013;88(3):456-7.
20. Espey E, Singh RH, Leeman L, Ogburn T, Fowler K, Greene H. Misoprostol for intrauterine device insertion in nulliparous women: A randomized controlled trial. American Journal of Obstetrics and Gynecology 2014;210(3):208.e1-5.
21. Gemzell-Danielsson K, Inki P, Boubli L, O'Flynn M, Kunz M, Heikinheimo O. Bleeding pattern and safety of consecutive use of the levonorgestrel-releasing intrauterine system (LNG-IUS)--a multicentre prospective study. Human Reproduction 2010;25(2):354-9.
22. Heikinheimo O, Inki P, Kunz M, Parmhed S, Anttila AM, Olsson SE, et al. Double-blind, randomized, placebo-controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel-releasing intrauterine system. Contraception 2010;81(6):481-6.
23. Hubacher D, Reyes V, Lillo S, Zepeda A, Chen P, Croxatto H. Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. American Journal of Obstetrics and Gynecology 2006;195(5):1272-7.
24. Ibrahim ZM, Sayed Ahmed WA. Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. European Journal of Contraception and Reproductive Health Care 2013;18(4):300-8.
25. Jensen HH, Blaabjerg J, Lyndrup J. Prophylactic use of prostaglandin synthesis inhibitors in connection with IUD insertion. Ugeskrift for Laeger 1998;160(48):6958-61.
26. Karabayirli S, Ayrim AA, Muslu B. Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology 2012;19(5):581-4.
27. Lathrop E, Haddad L, McWhorter CP, Goedken P. Self-administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. Contraception 2013;88(6):725-9.
28. Lotke P. Use of misoprostol for intrauterine device (IUD) insertion in nulliparous women. clinicaltrials.gov/show/NCT01001897 (accessed 28 October 2014).
29. Lotke PS, Tiwari A, Nuño VL. Inserting intrauterine devices in nulliparous women: is misoprostol beneficial? A registered clinical trial. American Journal of Clinical and Experimental Obstetrics Gynecology 2013;1(1):62-8.
30. Maguire K, Davis A, Rosario Tejeda L, WesthoffC. Intracervical lidocaine gel for intrauterine device insertion: a randomized controlled trial. Contraception 2012;86(3):214-9.
31. Maguire K, Davis A, Rosario Tejeda L, WesthoffCL. Intracervical 2% lidocaine gel as an analgesic during intrauterine device insertion: A randomized controlled trial (abstract). Contraception 2012;85(3):324.
32. Maguire K, Morrell K, WesthoffC, Davis A. Accuracy of providers' assessment of pain during intrauterine device insertion. Contraception 2014;89(1):22-4.
33. Massey SE, Varady JC, Henzl MR. Pain relief with naproxen following insertion of an intrauterine device. Journal of Reproductive Medicine 1974;13(6):226-31.
34. McNicholas C, Madden T, Zhao Q, Secura G, Allsworth J, Peipert J. Cervical lidocaine for IUD insertional pain: A randomized control trial (abstract). Contraception 2012;86(3):319.
35. McNicholas CP, Madden T, Zhao Q, Secura G, Allsworth JE, Peipert JF. Cervical lidocaine for IUD insertional pain: a randomized controlled trial. American Journal of Obstetrics and Gynecology 2012;207(5):384.e1-6.
36. Micks EA, Jensen JT, Bednarek PH. The effect of nitroglycerin on the IUD insertion experience in nulliparous women: a pilot study. Contraception 2014;90(1):60-5.
37. Krishnan S, Kiley J, Rademaker A, Gawron L, Stika C, Hammond C. Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block (abstract). Contraception 2011;84(3):319.
38. Mody SK, Kiley J, Rademaker A, Gawron L, Stika C, Hammond C. Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block. Contraception 2012;86(6):704-9.
39. Mohammad-Alizadeh-Charandabi S, Seidi S, Kazemi F. Effect of lidocaine gel on pain from copper IUD insertion: a randomized double-blind controlled trial. Indian Journal of Medical Sciences 2010;64(8):349-55.
40. Nelson AL, Fong JK. Intrauterine infusion of lidocaine does not reduce pain scores during IUD insertion. Contraception 2013;88(1):37-40.
41. Mody S. Pain control for intrauterine device placement: a Ttial of ketorolac prior to intrauterine device placement. clinicaltrials.gov/show/NCT01664559 (accessed 11 September 2014). [NCT01664559]
42. Ngo L, Ward K, Mody S. Pain control for intrauterine device insertion: a randomized double-blind controlled trial of ketorolac (abstract). Contraception 2014;90(3):297.
43. Rapkin RB. Self-administered intravaginal 2% lidocaine gel prior to intrauterine device insertion in nulliparous women (LIVIIN). clinicaltrials.gov/show/NCT01534520 (accessed 4 September 2014).
44. Rapkin RB, Achilles SL, Boraas C, Cremer M, Schwarz EB, Chen BA. Self-administered lidocaine gel for intrauterine device insertion in nulliparous women: a randomized controlled trial (abstract). Obstetrics and Gynecology 2014;123(5 (Suppl)):110S. [NCT01534520]
45. Sääv I, Aronsson A, Marions L, Stephansson O, Gemzell-Danielsson K. Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Human Reproduction 2007;22(10):2647-52.
46. Scavuzzi A, Souza AS, Costa AA, Amorim MM. Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Human Reproduction 2013;28(8):2118-25.
47. Shahnazi M, Nikjoo R, Yavarikia P, Mohammad-Alizadeh-Charandabi S. Inhaled lavender effect on anxiety and pain caused from intrauterine device insertion. Journal of Caring Sciences 2012;1(4):255-61.
48. Swenson C, Turok DK, Ward K, Jacobson JC, Dermish A. Self-administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial. Obstetrics and Gynecology 2012;120(2 Part 1):341-7.
49. Pharmanest AB 2013. A randomized, double blind, placebo controlled, parallel group clinical study investigating the analgesic effect and safety of a topical formulation of lidocaine (SHACT) during and after insertion of an Intra Uterine Device. A phase II study. www.clinicaltrialsregister.eu/ctr-search/trial/2011-006220-20/SE (accessed 22 January 2015).
50. Tingaker B, Brodin A, Irestedt L, Ekman-Ordeberg G. A novel mucosal pain relief drug candidate - SHACT -- gives highly significant analgesia at insertion of intra uterine device (IUD) (abstract). Reproductive Sciences 2014;21(3):318A.
51. Tornblom-Paulander S, Tingåker BK, Werner A, Liliecreutz C, Conner P, Wessel H, et al. Novel topical formulation of lidocaine provides significant pain relief for intrauterine device insertion: pharmacokinetic evaluation and randomized placebo-controlled trial. Fertility and Sterility 2015;103(2):422-7.
52. Goldstuck ND. Treatment of pain following IUD insertion with meptazinol-a new centrally acting analgesic. Contraceptive Delivery Systems: An International Journal 1983;4(1):33-7.
53. Hepburn S. Method of local anesthesia for IUD insertion. Contraceptive Delivery Systems 1980;1(4):371-82.
54. Hollingworth B. Pain control during insertion of intrauterine device. British Journal of Family Planning 1995;21(3):102-3.
55. Jafari A, Sayyahi M, Torkashvand R, Piryaei H. Effect of vitamin B1 on pain after insertion of intrauterine device [article in Persian]. Journal of Babol University of Medical Sciences 2014;16(3):13-20.
56. Mirmohamad Aliei M, Khazaie F, Rahnama P, Rahimikian F, Modarres M, Bekhradi R, et al. Effect of lavender on pain during insertion of intrauterine device: A clinical trial [article in Persian]. Journal of Babol University of Medical Sciences 2013;15(4):93-9.
57. Mirmohammadali AM. Effect of lavender essential oil on anxiety and pain during insertion of intrauterine device. apps.who.int/trialsearch/trial.aspx?trialid=IRCT201209266206N4 (accessed 29 July 2014). [IRCT201209266206N4]
58. Newton JR, Reading AE. The effects of psychological preparation on pain at intrauterine device insertion. Contraception 1977;16(5):523-32.
59. Oloto EJ, Bromham DR, Murty JA. Pain and discomfort perception at IUD insertion--effect of short-duration, low-volume, intracervical application of two percent lignocaine gel (Instillagel™)--a preliminary study. British Journal of Family Planning 1997;22(4):177-80.
60. Stephenson J. Does topical anaesthetic gel reduce pain/discomfort during intrauterine device (IUD)/intrauterine system (IUD) insertion? A randomised, placebo-controlled, double-blind trial. www.controlled-trials.com/ISRCTN83819888 (accessed 23 September 2014).
61. Teal S. IUD insertion in nulliparous women. clinicaltrials.gov/show/NCT01422226 (accessed 19 August 2014).
62. Thiery M. Pain relief at insertion and removal of an IUD: a simplified technique for paracervical block. Advances in Contraception 1985;1(2):167-70.
63. Brody K. Topical Lidocaine on the Cervix and Intra-Cervical Prior to Insertion of Intrauterine Devices (10-053). http://clinicaltrials.gov/show/NCT01192490 (accessed 17 September 2014).
64. Elsafty ASE. Efficacy study of topical application of lidocaine spray prior to IUD insertion. clinicaltrials.gov/show/NCT01496105 (accessed 18 September 2014).
65. Khodokarami N. The effect of chamomile essential oil on pain intensity of IUD insertion. www.irct.ir/searchresult.php?id=8950&number=1 (accessed 23 September 2014).
66. Singh R. Nitrous oxide for pain management of IUD insertion (NIUD). clinicaltrials.gov/ct2/show/NCT02391714 (accessed 4 May 2015). [DOI: NCT02391714]
67. Singh RH, Thaxton LD, Carr S, Leeman LM, Schneider E, Espey E. Nitrous oxide for intrauterine device insertion in nulliparous women: a randomized controlled trial [22]. Obstetrics and Gynecology 2015;125(Suppl 1):7S.
68. Fouda UM. Diclofenac plus lidocaine gel for pain relief during intrauterine device insertion (IUD). clinicaltrials.gov/show/NCT02332057 (accessed 27 January 2015).
69. Jamshidi R. Study of local anesthesia as a method to decrease IUD insertion related pain. clinicaltrials.gov/show/NCT01967017 (accessed 11 September 2013).
70. Mody S, Culwell K. Pain control for intrauterine device placement using paracervical block. clinicaltrials.gov/show/NCT02219308 (accessed 11 September 2014).
71. Allen RH, Carey MS, Raker C, Goyal V, Matteson K. A prospective cohort study of pain with intrauterine device insertion among women with and without vaginal deliveries. Journal of Obstetrics and Gynaecology 2014;34(3):263-7.
72. Asker C, Stokes-Lampard H, Beavan J, Wilson S. What is it about intrauterine devices that women find unacceptable? Factors that make women non-users: a qualitative study. Journal of Family Planning and Reproductive Health Care 2006;32(2):89-94.
73. Bahamondes L, Mansour D, Fiala C, Kaunitz AM, Gemzell-Danielsson K. Practical advice for avoidance of pain associated with insertion of intrauterine contraceptives. Journal of Family Planning and Reproductive Health Care 2014;40(1):54-60.
74. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011;64(4):401-6.
75. Committee on Adolescent Health Care, Long-Acting Reversible Contraception Working Group. American College of Obstetricians Gynecologists Committee Opinion no. 539: Adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstetrics and Gynecology 2012;120(4):983-8.
76. Gemzell-Danielsson K, Mansour D, Fiala C, Kaunitz AM, Bahamondes L. Management of pain associated with the insertion of intrauterine contraceptives. Human Reproduction Update 2013;19(4):419-27.
77. Goldberg AB, Carusi DA, Meckstroth KR. Misoprostol in gynecology. Current Women's Health Reports 2003;3(6):475-83.
78. Goldstuck ND, Mathews ML. A comparison of the actual and expected pain response following insertion of an intrauterine contraceptive device. Clinical Reproduction and Fertility 1985;3(1):65-71.
79. Grimes DA, Hubacher D, Lopez LM, Schulz KF. Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with IUD use. Cochrane Database of Systematic Reviews 2006;4:CD006034.
80. Grimes DA, Mishell DR. Intrauterine contraception as an alternative to interval tubal sterilization. Contraception 2008;77(1):6-9.
81. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383-94.
82. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org (accessed 25 March 2014).
83. Kaislasuo J, Heikinheimo O, Lähteenmäki P, Suhonen S. Predicting painful or difficult intrauterine device insertion in nulligravid women. Obstetrics and Gynecology 2014;124(2 Pt 1):345-53.
84. Kass-WolffJH, Fisher JE. Evidence-based pain management for endometrial biopsies and IUD insertions. Nurse Practitioner 2014;39(3):43-50.
85. Mercier RJ, Zerden ML. Intrauterine anesthesia for gynecologic procedures: a systematic review. Obstetrics and Gynecology 2012;120(3):669-77.
86. Murty J. Use and effectiveness of oral analgesia when fitting an intrauterine device. Journal of Family Planning and Reproductive Health Care 2003;29(3):150-1.
87. Ott MA, Sucato GS, Committee on Adolescence. Contraception for adolescents. Pediatrics 2014;134(4):e1257-81.
88. Pergialiotis V, Vlachos DG, Protopappas A, Vlachos GD. Analgesic options for placement of an intrauterine contraceptive: a meta-analysis. European Journal of Contraception and Reproductive Health Care 2014;19(3):149-60.
89. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
90. Thomson AJ, Lunan CB, Cameron AD, Cameron IT, Greer IA, Norman JE. Nitric oxide donors induce ripening of the human uterine cervix: a randomised controlled trial. British Journal of Obstetrics and Gynaecology 1997;104(9):1054-1057.
91. Tolcher R. Intrauterine techniques: contentious or consensus opinion?. Journal of Family Planning and Reproductive Health Care 2003;29(1):21-4.
92. Turok DK, Espey E, Edelman AB, Lotke PS, Lathrop EH, Teal SB, et al. The methodology for developing a prospective meta-analysis in the family planning community. Trials 2011;12:104.
93. United Nations Population Division. World Contraceptive Patterns 2013. www.un.org/en/development/desa/population/publications/family/contraceptive-wallchart-2013.shtml (accessed 11 February 2015).
94. Waddington A, Reid R. More harm than good: the lack of evidence for administering misoprostol prior to IUD insertion. Journal of Obstetrics and Gynaecology Canada 2012;34(12):1177-9.